NHS National Generic Pharmaceuticals Wave 13
Buyers
Value
£469,741,550
Suppliers
- Pfizer Ltd
- Merck Sharpe & Dohme (UK) Limited
- Allergan
- Medreich PLC
- Ennogen Healthcare Ltd
- GLAXOSMITHKLINE UK LIMITED
- Syri Limited (T/A Thame Laboratories)
- Hameln Pharma Ltd
- medac Pharma LLP
- Martindale Pharma
- Rosemont Pharmaceuticals Limited
- Mercury Pharmaceuticals Limited
- Selective Supplies Ltd.
- Nexcape Pharmaceuticals Ltd.
- Consilient Health Ltd
- Sandoz Ltd
- Fresenius Kabi Limited
- Glenmark Pharmaceuticals Europe Limited
- Laboratorio Reig Jofre SA
- Kent Pharma Ltd
- Bowmed Ibisqus Limited
- Panpharma UK Limited
- Kensington Pharma Ltd
- Healthcare Pharma Ltd
- Thornton and Ross Ltd
- Mylan
- Macleods Pharma UK Limited
- Wockhardt UK Limited
- Thea Pharmaceuticals Limited
- Dr Falk Pharma UK Ltd
- Desitin Pharma Ltd
- Stragen UK Ltd
- B. BRAUN MEDICAL LIMITED
- Torrent Pharma UK Ltd
- Fontus Health Ltd
- ASPIRE PHARMA LIMITED
- Teva UK Limited
- AMAROX LIMITED
- AOP Orphan Ltd
- Pierre Fabre Ltd
- Macure Pharma ApS
- Ranbaxy UK
- Arcadia Pharma Ltd T/A Arcadia Medical
- Derma UK
- Zista Pharma Ltd
- Dr.Reddy's Laboratories (UK) Limited
- ASPEN PHARMACARE UK LIMITED
- Manx Healthcare Ltd
- Colonis Pharma Ltd
- Roche Products Ltd
- Waverley Pharma Europe Limited
- Profile Pharma Ltd
- Reckitt Benckiser
- Zentiva Pharma UK Ltd
- Baxter Healthcare Ltd
- Organon Pharmaceuticals UK Ltd
- Day Lewis Medical Ltd
- LogixX Pharma Ltd
- Lundbeck Limited
- Napp Pharmaceuticals Ltd
- Bayer Ltd
- Recordati Rare Diseases UK Ltd
- Morningside Pharmaeuticals
- Dexcel Pharma Ltd
- CST Pharma Limited
- Cipla (EU) Ltd
- Flexipharm Austrading Limited
- Relonchem Ltd
- LEO Pharma
- Aguettant Ltd
- Torbay Pharmaceuticals
- RPH Pharmaceuticals AB
- DRUGSRUS LTD
- Ferring Pharmaceuticals Ltd
- Milpharm Ltd/aurobinbdo
- PARI
- Crescent Pharma Ltd
- Roma Pharmaceuticals Limited
- Kyowa Kirin Ltd
- Brown & Burk UK Ltd
- Seacross Pharmaceuticals Ltd
- Lupin Healthcare (UK) Limited
- ALLIANCE PHARMACEUTICALS LIMITED
- Bristol Laboratories Limited
- ARISTO PHARMA LIMITED
- Synchrony
- ALISSA HEALTHCARE RESEARCH LIMITED
- Altan Pharma Ltd
- Lucane Pharma
- Norgine Pharmaceuticals Limited
- Neon Healthcare Ltd
- Aventis Pharma ltd t/a Sanofi
- MIP Pharma GmbH
- ACCORD-UK LTD
- ACIUM LTD
- Ascend Laboratories UK Ltd
- Rivopharm UK Ltd
- Strides Pharma Uk LTD
- V Pharma
Classifications
- Pharmaceutical products
Tags
- award
Submission Deadline
3 years ago
Published
2 years ago
Description
Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Organisation
Gemma Tomlinson/Lynne Tierney
Timeline complete
Complete